|
1
|
Satin LS, Butler PC, Ha J and Sherman AS:
Pulsatile insulin secretion, impaired glucose tolerance and type 2
diabetes. Mol Aspects Med. 42:61–77. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lang DA, Matthews DR, Burnett M, Ward GM
and Turner RC: Pulsatile, synchronous basal insulin and glucagon
secretion in man. Diabetes. 31:22–26. 1982.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Pørksen N: The in vivo regulation of
pulsatile insulin secretion. Diabetologia. 45:3–20. 2002.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Pørksen N, Nyholm B, Veldhuis JD, Butler
PC and Schmitz O: In humans at least 75% of insulin secretion
arises from punctuated insulin secretory bursts. Am J Physiol.
273:E908–E914. 1997.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Scheen AJ, Sturis J, Polonsky KS and Van
Cauter E: Alterations in the ultradian oscillations of insulin
secretion and plasma glucose in aging. Diabetologia. 39:564–572.
1996.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Aoki TT, Benbarka MM, Okimura MC,
Arcangeli MA, Walter RM Jr, Wilson LD, Truong MP, Barber AR and
Kumagai LF: Long-term intermittent intravenous insulin therapy and
type 1 diabetes mellitus. Lancet. 342:515–518. 1993.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Matthews DR, Naylor BA, Jones RG, Ward GM
and Turner RC: Pulsatile insulin has greater hypoglycemic effect
than continuous delivery. Diabetes. 32:617–621. 1983.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Weinrauch LA, Burger AJ, Aepfelbacher F,
Lee AT, Gleason RE and D'Elia JA: A pilot study to test the effect
of pulsatile insulin infusion on cardiovascular mechanisms that
might contribute to attenuation of renal compromise in type 1
diabetes mellitus patients with proteinuria. Metabolism.
56:1453–1457. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Weinrauch LA, Bayliss G, Gleason RE, Lee
AT and D'Elia JA: Utilization of an abbreviated diabetes impact
management scale to assess change in subjective disability during a
trial of pulsatile insulin delivery demonstrates benefit.
Metabolism. 58:488–491. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Dailey GE, Boden GH, Creech RH, Johnson
DG, Gleason RE, Kennedy FP, Weinrauch LA, Weir M and D'Elia J88A:
Effects of pulsatile intravenous insulin therapy on the progression
of diabetic nephropathy. Metabolism. 49:1491–1495. 2000.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pørksen NK, Munn SR, Steers JL, Schmitz O,
Veldhuis JD and Butler PC: Mechanisms of sulfonylurea's stimulation
of insulin secretion in vivo: Selective amplification of insulin
secretory burst mass. Diabetes. 45:1792–1797. 1996.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Juhl CB, Hollingdal M, Pørksen N, Prange
A, Lönnqvist F and Schmitz O: Influence of rosiglitazone treatment
on beta-cell function in type 2 diabetes: Evidence of an increased
ability of glucose to entrain high-frequency insulin pulsatility. J
Clin Endocrinol Metab. 88:3794–3800. 2003.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Juhl CB, Gjedsted J, Nielsen MF and
Schmitz O: Increased action of pulsatile compared to non-pulsatile
insulin delivery during a meal-like glucose exposure simulated by
computerized infusion in healthy humans. Metabolism. 61:1177–1181.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Skjaervold NK, Ostling D, Hjelme DR,
Spigset O, Lyng O and Aadahl P: Blood glucose control using a novel
continuous blood glucose monitor and repetitive intravenous insulin
boluses: Exploiting natural insulin pulsatility as a principle for
a future artificial pancreas. Int J Endocrinol.
2013(245152)2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Aoki TT, Grecu EO, Arcangeli MA, Benbarka
MM, Prescott P and Ahn JH: Chronic intermittent intravenous insulin
therapy: A new frontier in diabetes therapy. Diabetes Technol Ther.
3:111–123. 2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livesey G and Elia M: Estimation of energy
expenditure, net carbohydrate utilization, and net fat oxidation
and synthesis by indirect calorimetry: Evaluation of errors with
special reference to the detailed composition of fuels. Am J Clin
Nutr. 47:608–628. 1988.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Haugen HA, Chan LN and Li F: Indirect
calorimetry: A practical guide for clinicians. Nutr Clin Pract.
22:377–388. 2007.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhao J, Wang ZY, Li J, Yu HW and Meng QH:
Influence of diabetes mellitus on energy metabolism in patients
with alcoholic liver cirrhosis. Eur J Gastroenterol Hepatol.
32:110–115. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Graf S, Karsegard VL, Viatte V, Heidegger
CP, Fleury Y, Pichard C and Genton L: Evaluation of three indirect
calorimetry devices in mechanically ventilated patients: Which
device compares best with the Deltatrac II®? A
prospective observational study. Clin Nutr. 34:60–65.
2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Körner A, Eklöf AC, Celsi G and Aperia A:
Increased renal metabolism in diabetes. Mechanism and functional
implications. Diabetes. 43:629–633. 1994.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Gonzalez C, Fagour C, Maury E, Cherifi B,
Salandini S, Pierreisnard A, Masquefa-Giraud P, Gin H and Rigalleau
V: Early changes in respiratory quotient and resting energy
expenditure predict later weight changes in patients treated for
poorly controlled type 2 diabetes. Diabetes Metab. 40:299–304.
2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Perseghin G, Lattuada G, De Cobelli F,
Esposito A, Costantino F, Canu T, Scifo P, De Taddeo F, Maffi P,
Secchi A, et al: Reduced intrahepatic fat content is associated
with increased whole-body lipid oxidation in patients with type 1
diabetes. Diabetologia. 48:2615–2621. 2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Meyer HU, Curchod B, Maeder E, Pahud P,
Jequier E and Felber JP: Modifications of glucose storage and
oxidation in nonobese diabetics, measured by continuous indirect
calorimetry. Diabetes. 29:752–756. 1980.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Thalacker-Mercer AE, Ingram KH, Guo F,
Ilkayeva O, Newgard CB and Garvey WT: BMI, RQ, diabetes, and sex
affect the relationships between amino acids and clamp measures of
insulin action in humans. Diabetes. 63:791–800. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Buscemi S, Donatelli M, Grosso G, Vasto S,
Galvano F, Costa F, Rosafio G and Verga S: Resting energy
expenditure in type 2 diabetic patients and the effect of insulin
bolus. Diabetes Res Clin Pract. 106:605–610. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mirbolooki MR, Taylor GE, Knutzen VK,
Scharp DW, Willcourt R and Lakey JR: Pulsatile intravenous insulin
therapy: The best practice to reverse diabetes complications? Med
Hypotheses. 73:363–369. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Aoki TT, Grecu EO, Prendergast JJ,
Arcangeli MA and Meisenheimer R: Effect of chronic intermittent
intravenous insulin therapy on antihypertensive medication
requirements in IDDM subjects with hypertension and nephropathy.
Diabetes Care. 18:1260–1265. 1995.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nieves-Cintrón M, Syed AU, Nystoriak MA
and Navedo MF: Regulation of voltage-gated potassium channels in
vascular smooth muscle during hypertension and metabolic disorders.
Microcirculation. 25:2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Pietruczuk P, Jain A, Simo-Cheyou ER,
Anand-Srivastava MB and Srivastava AK: Protein kinase B/AKT
mediates insulin-like growth factor 1-induced phosphorylation and
nuclear export of histone deacetylase 5 via NADPH oxidase 4
activation in vascular smooth muscle cells. J Cell Physiol.
234:17337–17350. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bratusch-Marrain PR, Komjati M and
Waldhäusl WK: Efficacy of pulsatile versus continuous insulin
administration on hepatic glucose production and glucose
utilization in type I diabetic humans. Diabetes. 35:922–926.
1986.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yang H, Wang X, Meng Z, Zhang R, Zhou Y
and Zhao Y: Analysis of influence factors of adverse reactions to
oral glucose tolerance test in healthy people. J Nur. 17:23–25.
2010.
|
|
32
|
Fan L, Wang G, Tao X, Hong B, Li H and
Huang Y: Study on the influencing factors of adverse reactions in
1110 oral glucose tolerance tests. Chin Nur J. 29:387–390.
1994.
|
